Participants were randomized to placebo or retatrutide at 1 mg, 4 mg (dose-escalation), 4 mg (no escalation), 8 mg (escalation), 8 mg (no escalation), or 12 mg (escalation) for 48 weeks, following a slow titration protocol
Disruption of the AMPKOXPHOS axis has been shown to sensitize CSCs to chemotherapy, underscoring its potential as a therapeutic target [61]
CRC Group is well-equipped to handle the exposures associated with GLP-1 medications, drawing on extensive experience and expertise within the healthcare space
Book your consultation here
Mxima calidad alimentaria
For current customers, those decisions will be made with the renewal of their health plan, the statement said